SAN JOSE, Calif. — November 24, 2025 — Leads & Copy — Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company specializing in the oral delivery of biologics and drugs, will participate in the upcoming 8th Annual Evercore Healthcare Conference in Coral Gables, FL.
The conference is scheduled for Wednesday, December 3, 2025, at 8:45 a.m. E.T. Rani Therapeutics’ Chief Executive Officer, Talat Imran, and Chief Financial Officer, Svai Sanford, will be presenting a fireside chat and participating in 1×1 meetings.
Interested parties can access the live webcast of the conference via the Investor Relations section of Rani Therapeutics’ website. A replay of the webcast will be available following the presentation.
Rani Therapeutics is focused on creating technologies for the oral administration of biologics and drugs. The company’s RaniPill® capsule is a patented platform technology designed to replace subcutaneous injections or intravenous infusions with oral dosing. The company has conducted preclinical and clinical studies to assess the safety, tolerability, and bioavailability of the RaniPill® capsule technology.
Investor Contact: investors@ranitherapeutics.com
Media Contact: media@ranitherapeutics.com
Source: Rani Therapeutics
Source: Rani Therapeutics
